Journal Information
Scientific Letter
Full text access
Hydroxychloroquine as Prophylaxis for Coronavirus SARS-CoV-2 Infection: Review of the Ongoing Clinical Trials
Hidroxicloroquina como profilaxis para la infección por coronavirus SARS-CoV-2: revisión de los ensayos clínicos en curso
Virgilio Galvisa,b,c, Francesca Romana Spinellid, Alejandro Telloa,b,c,
, Claudia L. Sossab,c, Juan D. Higuerab,c, Edgar D. Gómezb,c, Sergio E. Serranoc, Paul A. Camachob,c, Federico G. Veleze,f
Corresponding author
a Centro Oftalmológico Virgilio Galvis, Floridablanca, Colombia
b Fundación Oftalmológica de Santander FOSCAL, Floridablanca, Colombia
c Faculty of Health Sciences, Universidad Autónoma de Bucaramanga UNAB, Bucaramanga, Colombia
d Department of Clinical Sciences, Internal Medicine, Anesthesiology and Cardiovascular Diseases – Rheumatology, Sapienza University of Rome, Rome, Italy
e Department of Ophthalmology, University of California Los Angeles, Los Angeles, California, United States
f Department of Ophthalmology, Duke University, Durham, North Carolina, United States
Article
This article is available in English
Hydroxychloroquine as Prophylaxis for Coronavirus SARS-CoV-2 Infection: Review of the Ongoing Clinical Trials
Virgilio Galvis, Francesca Romana Spinelli, Alejandro Tello, Claudia L. Sossa, Juan D. Higuera, Edgar D. Gómez, Sergio E. Serrano, Paul A. Camacho, Federico G. Velez
10.1016/j.arbres.2020.05.008Arch Bronconeumol. 2020;56:606-8